Welcome to Phase V Technologies.

We will help you find the drug development tool for measuring outcomes with greater reliability, sensitivity and validity by using information technology and data science technologies.

Request a demo of our Phase V® Outcomes Information System (PVOIS) modules for remote monitoring, mobile electronic diaries, patient reported surveys and biosensors.

Quality Service

Dedicated training through the Phase V Learning Management System and online and telephone support improve the quality of the data.

Good Support

Each clinical site has its own website with on-call help desk technicians to aid in using our remote sensing devices and web portals.

We Go Beyond The Expected To Find
The Best Possible Solution

Clients Say About Us

Meet Our Great Team


Marcia Testa

Chairman and Faculty Founder

Essential Business Skills

Nulla ut fringilla dui. Nullam sit amet pulvinar velit, at rutrum lacus. Aliquam scelerisque mat.

web design 85% 85%
development 65% 65%
graphic design 85% 85%
web design 50% 50%

Latest News


805-P — 2012: Improved Glycemic Control and Variability During Insulin Intensification Improve Patient-Centered Outcomes in Type 1 Diabetes

Psychosocial – Behavioral Medicine Presented on Saturday, June 9, 2012 11:30 AM Author(s):  MARCIAA. TESTA,.

850-P — 2012: Assessing the Comparative Effectiveness (CE) of Basal-Bolus vs. Premix Insulin Using Continuous Glucose Monitoring (CGM) Summary Measures

Clinical Therapeutics/New Technology – Glucose Monitoring and Sensing Presented on Sunday, June 10, 2012 12:00.

Impact of Weight Loss on Patient-Reported Outcomes in Obese Type 2 Diabetes

Session: New Findings from Controlled Behavioral Interventions Abstract Number: 1-OR Title: Impact of Weight Loss.